title: Pretreatment predictors of death from other causes in men with prostate cancer.
abstract: OBJECTIVE
  Most men diagnosed with prostate cancer will die of other causes and pretreatment patient characteristics may identify those who are likely to die of other causes. Accurate stratification of patients by risk of other cause mortality may reduce needless treatment preventing morbidity and expense.
  
  
  METHODS
  Using the CaPSURE database a cohort of men was identified with clinically localized prostate cancer who had definitive treatment with radical prostatectomy or radiation therapy between 1995 and 2004. Pretreatment patient characteristics were evaluated to determine if early other cause mortality could be predicted.
  
  
  RESULTS
  Of 13,124 subjects enrolled in CaPSURE 5,070 had clinical T1c-T3a prostatic adenocarcinoma treated with radical prostatectomy (77%) or radiation therapy (23%) and posttreatment followup data. Median followup was 3.3 years. The cohort was divided into 3 groups. The prostate cancer specific mortality group included 55 men (1%) who died of prostate cancer. The 296 men (6%) who died of causes other than prostate cancer comprised the other cause mortality group. A third group contained the 4,719 (93%) men surviving at the end of the observation period. Factors that exclusively predicted death from nonprostate cancer causes included age at diagnosis, having a high school education or less, high clinical risk, smoking at time of diagnosis, concurrent nonprostate malignancy and worse scores on the Short Form-36 Health Survey physical function scale.
  
  
  CONCLUSIONS
  Several pretreatment patient characteristics may identify patients at high risk of nonprostate cancer mortality. Future studies should consider stratifying patients by or at least reporting these variables.
authors.affiliation: Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: Nicole L
authors.initials: NL
authors.lastname: Simone
authors.forename: Anurag K
authors.initials: AK
authors.lastname: Singh
authors.forename: Janet E
authors.initials: JE
authors.lastname: Cowan
authors.forename: Benjamin P
authors.initials: BP
authors.lastname: Soule
authors.forename: Peter R
authors.initials: PR
authors.lastname: Carroll
authors.forename: Mark S
authors.initials: MS
authors.lastname: Litwin
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000628:therapy; D000368:Aged; D002423:Cause of Death; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000150:complications / Q000628:therapy; D012307:Risk Factors